Table 2.
Author | Title | Data source used | Primary outcome | Best model performance | Study conclusion |
---|---|---|---|---|---|
Hoda (26) | Prediction of cyclosporine blood levels in heart transplantation patients using a pharmacokinetic model identified by evolutionary algorithms | Local institutional data from the Heart and Lung Transplantation Center, University of Vienna Medical School | Cyclosporin blood level | Evolutionary algorithms model had a mean percent error of 8.0 ± 6.7%. | AI model accurately predicted cyclosporine whole blood levels in heart transplant recipients. |
Chen (24) | Quantitative 3D analysis of coronary wall morphology in heart transplant patients: OCT-assessed cardiac allograft vasculopathy progression | Local patients at Transplant Center at Institute of Clinical and Experimental Medicine and the Center for Cardiovascular and Transplantation Surgery, Brno, Czech | Coronary artery intimal thickness | Exclusion regions determined by transfer learning using ImageNet network achieved an accuracy of 81.2%. | AI allows quantification of location-specific alterations of coronary wall morphology over time and is sensitive even to very small changes of wall layer thicknesses. |
Peyster (22) | An automated computational image analysis pipeline for histological grading of cardiac allograft rejection | Local institutional data at Hospital of the University of Pennsylvania, Cleveland Medical Center, and the Ohio State University Wexner Medical Center | Histopathologic rejection detection | A support vector machine classification model had an AUC of 0.92. | The grader pipeline, derived using intuitive morphological features, can provide expert-quality rejection grading. |
Woillard (27) | Tacrolimus exposure prediction using machine learning | local institutional data | Blood concentration of tacrolimus (TAC) following twice daily vs. daily dosing | XBBoost models to estimate TAC blood AUC based on 2 measurements showed mean prediction error close to 0; and root mean square error < 10%. | AI allows accurate estimation of TAC interdose AUC and can be used for routine TAC exposure estimation and dose adjustment. |
Lipkova (21) | Deep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsies | local institutional data from the Brigham and Women’s Hospital | Histopathologic rejection detection, classification, and grading | A neural network (transfer learning from ResNet50 and attention-based multiple instance learning) model had an AUC of 0.962 for detecting allograft rejection. | The AI system showed non-inferior performance to experts and reduced interobserver variability and assessment time. |
Piening (23) | Whole transcriptome profiling of prospective endomyocardial biopsies reveals prognostic and diagnostic signatures of cardiac allograft rejection | Local data from the CTOT-03 trial (NCT:0053192) population from University of Pennsylvania and the University of Wisconsin | A gene expression classifier for 0R/1R vs. 2R acute rejection | Random Forest model had an AUC of 0.947. | RNA-seq-based molecular characterization of EMBs shows significant promise for the early detection of cardiac allograft rejection. |
Wei (25) | The novel proteomic signature for cardiac allograft vasculopathy | Local patients at University Hospitals Leuven, Belgium | Detection of cardiac allograft vasculopathy (CAV) | XgBoost model showed an AUC 0.71, 95% CI 0.60–0.81. | The proteomic signature might provide insights into CAV pathological processes and help study personalized treatment targets. |
strong recommendation, weak recommendation/promising but not ready to implement, as suggested by the respective paper.